Overview Fundamentals API Earnings EOD API Sample Code Pricing

TTY Biopharm Co Ltd (4105 TWO) stock market data APIs

NT$73.8 0.2(0.3%) as of October 22, 2024
Price chart is built with Anychart

TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, and Other Business Unit segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre names for anti-cancer and supplementary treatments. The company provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu. In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism. Further, the company engages in the selling functional foods; and import and export trading and investment activities. The company was incorporated in 1960 and is headquartered in Taipei, Taiwan.

TTY Biopharm Co Ltd Financial Data Overview

73.6
73.8
-
73.8
73.5
69.5-87
18 301 M
16.3193
249 M
5 726 M
1.13
0.0474
0.192
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '4105',
Type: 'Common Stock',
Name: 'TTY Biopharm Co Ltd',
Exchange: 'TWO',
CurrencyCode: 'TWD',
CurrencyName: 'New Taiwan Dollar',
CurrencySymbol: 'NT$',
CountryName: 'Taiwan',
CountryISO: 'TW',
OpenFigi: NULL,
ISIN: 'TW0004105002',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

TTY Biopharm Co Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 5 726 M
  • EBITDA 1 567 M
  • Earnings Per Share 4.51
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get TTY Biopharm Co Ltd Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast NaN

Get TTY Biopharm Co Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com